These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 11354390

  • 1. Pharmacokinetics and tolerability of extended-release clarithromycin.
    Guay DR, Gustavson LE, Devcich KJ, Zhang J, Cao G, Olson CA.
    Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
    [Abstract] [Full Text] [Related]

  • 2. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ, Perry CM.
    Am J Respir Med; 2003 Apr; 2(2):175-201. PubMed ID: 14720016
    [Abstract] [Full Text] [Related]

  • 3. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis.
    Weiss K, Vanjaka A, Canadian Clarithromycin Study Group on Bronchitis.
    Clin Ther; 2002 Dec; 24(12):2105-22. PubMed ID: 12581548
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 5. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
    Adler JL, Jannetti W, Schneider D, Zhang J, Palmer R, Notario G.
    Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Notario G, Spiller J, Palmer R, Busman T.
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A, Fisher CL, Busman T, Olson CA.
    Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
    [Abstract] [Full Text] [Related]

  • 8. Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
    Gotfried MH.
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):9-20. PubMed ID: 15482099
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
    Jenner P, Könen-Bergmann M, Schepers C, Haertter S.
    Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
    [Abstract] [Full Text] [Related]

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 11. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis.
    Murray JJ, Solomon E, McCluskey D, Zhang J, Palmer R, Notario G.
    Clin Ther; 2000 Dec; 22(12):1421-32. PubMed ID: 11192134
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS.
    Jacobson MA, Nicolau DP, Sutherland C, Smith A, Aweeka F.
    HIV Clin Trials; 2005 Dec; 6(5):246-53. PubMed ID: 16306031
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D, Glaser-Caldow E, Wachter J, Brueckner OJ, Hein J, Kroemer B, Hirsch J.
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [Abstract] [Full Text] [Related]

  • 14. Clarithromycin extended-release in community-acquired respiratory tract infections.
    Williams KN, Bishai WR.
    Expert Opin Pharmacother; 2005 Dec; 6(16):2867-76. PubMed ID: 16318437
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, COMACS Study Group.
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [Abstract] [Full Text] [Related]

  • 18. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF, Ducharme MP, DiMarco M, Di Spirito M, Morelli G, Tippabhotla SK, Badri N, Rampal A, Monif T.
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [Abstract] [Full Text] [Related]

  • 19. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P, Donahue S, Meeker J, Marathe P.
    Clin Pharmacokinet; 2005 Dec; 44(7):721-9. PubMed ID: 15966755
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T, Hou E, Kasichayanula S, Berner B.
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.